Prothena Corp Public (PRTA) EBT (2012 - 2026)
Prothena Corp Public's (PRTA) quarterly EBT came in at $32.7 million in Q1 2026, up 153.32% year-on-year from $12.9 million in Q1 2025, and up 251.64% quarter-over-quarter from -$21.6 million in Q4 2025.
Prothena Corp Public (PRTA) EBT (2012 - 2026) Analysis & Trends
Prothena Corp Public's EBT history runs 15 years deep, the most recent figure standing at $32.7 million for Q1 2026.
- On a quarterly basis, EBT rose 153.32% year-over-year to $32.7 million in Q1 2026; TTM through Mar 2026 was -$106.7 million, a 7.88% increase from a year earlier, with the FY2025 full-year figure at -$200.8 million, down 55.77% from the prior year.
- EBT climbed to $32.7 million in Q1 2026 per PRTA's latest filing, from -$21.6 million in the prior quarter.
- Across five years, EBT topped out at $64.8 million in Q2 2024 and bottomed at -$81.0 million in Q2 2025.
- The 5-year median for EBT is -$48.4 million (2022), against an average of -$34.3 million.
- Across the five-year window, EBT tumbled 2211.15% in 2023 and surged 210.09% in 2024, its largest moves.
- Year by year, EBT stood at $3.3 million in 2022, then tumbled by 2211.15% to -$70.6 million in 2023, then advanced by 15.74% to -$59.5 million in 2024, then surged by 63.73% to -$21.6 million in 2025, then jumped by 251.64% to $32.7 million in 2026.
- Per Business Quant, the three latest PRTA EBT figures stand at $32.7 million (Q1 2026), -$21.6 million (Q4 2025), and -$36.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.31 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 259.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 438.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Prothena Corp Public | 467.80 Mn | 138.33 Mn | - | 32.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.72 Mn |
| Dec 31, 2025 | -21.58 Mn |
| Sep 30, 2025 | -36.91 Mn |
| Jun 30, 2025 | -80.97 Mn |
| Mar 31, 2025 | -61.37 Mn |
| Dec 31, 2024 | -59.50 Mn |
| Sep 30, 2024 | -59.84 Mn |
| Jun 30, 2024 | 64.85 Mn |
| Mar 31, 2024 | -74.44 Mn |
| Dec 31, 2023 | -70.62 Mn |
| Sep 30, 2023 | 18.82 Mn |
| Jun 30, 2023 | -58.90 Mn |
| Mar 31, 2023 | -49.78 Mn |
| Dec 31, 2022 | 3.35 Mn |
| Sep 30, 2022 | -48.42 Mn |
| Jun 30, 2022 | -42.57 Mn |
| Mar 31, 2022 | -37.96 Mn |
| Dec 31, 2021 | -33.10 Mn |
| Sep 30, 2021 | 109.20 Mn |
| Jun 30, 2021 | 27.90 Mn |